QUINTESSENTIAL-2

Phase 3 Clinical Trial Comparing the Safety and Efficacy of BMS-986393 to Standard of Care Regimens in Patients with Relapsed/Refractory Multiple Myeloma

Near Add Your Location

Sorting 12 by

UCLA Medical Center, Santa Monica
UCLA Health
Santa Monica, CA
  • Accepting patients
Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients
Fox Chase Cancer Center
Temple Health
Philadelphia, PA
  • Accepting patients
Huntsman Cancer Institute
University of Utah
Salt Lake City, UT
  • Not yet accepting
University of Alabama at Birmingham
O'Neal Comprehensive Cancer Center
Birmingham, AL
  • Not yet accepting
Sylvester Comprehensive Cancer Center (Main)
University of Miami Health System
Miami, FL
  • Not yet accepting
Vancouver General Hospital
Vancouver, BC
  • Not yet accepting
Tom Baker Cancer Centre
Alberta Health Services
Calgary, AB
  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.